Cancertope

In silico Platform for designing genome-based
Personalized immunotherapy or Vaccine against Cancer

Predicted Immune Epitope Results


The result page of search shows exclusive peptide/epitopes generated due to mutation [Neoepitope], the tissue of origin [Tissue], position of peptide in protein [Position], number of mismatches counted by aligning mutated and normal protein sequence [Num Mismatch, percentage of cell lines with this peptide over total number of cell lines [Promiscuity %]. The immune information include CTL epitopes (Yes/No), MHC I binders, MHC II binders (both given as number of alleles) and B cell epitopes (Yes/No). For more information, please click HERE


NeoepitopesVFVRDPAKI        Click here to BLAST against human proteome
CTL Epitope
(CTLPred)
N
HLA I Alleles
(ProPred I)
HLA-A24, HLA-B*51, HLA-B*5102, HLA-Cw*0401, MHC-Db, MHC-Kd, MHC-Kk7
HLA I Alleles
(nHLAPred)
NA0
HLA II Alleles
(PrePred)
DRB1_0402, DRB1_0801, DRB1_0802, DRB1_0804, DRB1_0806, DRB1_0813, DRB1_0817, DRB1_1301, DRB1_1327, DRB1_132810
B_Cell_Epitope
(ABCPred)
Y

CANCERTOPE    |     Raghava's Group    |     IMTECH    |     CSIR    |     CRDD    |     GPSR Package